Search for: "LUPIN PHARMACEUTICALS, INC."
Results 41 - 60
of 120
Sorted by Relevance
|
Sort by Date
18 Jan 2024, 9:16 am
Additionally, Lupin Ltd. and Lupin Pharmaceuticals, Inc. [read post]
17 Sep 2007, 2:00 pm
See Aventis Pharma Deutschland Gmbh and King Pharmaceuticals, Inc., v. [read post]
30 Sep 2013, 8:12 am
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
1 Jun 2018, 7:21 am
" Endo Pharmaceuticals Inc. v. [read post]
17 Feb 2010, 8:00 am
Lupin Ltd. and Lupin Pharmaceuticals Inc. [read post]
21 Nov 2012, 11:32 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
3 Aug 2012, 9:51 am
Inc. v. [read post]
30 Apr 2019, 3:24 am
May 30, 2019 - 1 PM: Lupin Pharmaceuticals, Inc. v. [read post]
13 Feb 2008, 6:19 pm
Lupin Pharmaceuticals, Inc., No. 1:2008cv00239, filed January 28, 2008; assigned to J. [read post]
22 Jul 2010, 11:07 am
Lupin Pharmaceuticals, Inc. [read post]
20 Jan 2011, 1:03 pm
Patent No. 7,101,574 ("the ‘574 patent") covering ANTARA (fenofibrate) Capsules, which is approved under NDA No. 21-695, and granted a Motion to Dismiss filed by defendants Ethypharm S.A., Lupin Limited, and Lupin Pharmaceuticals, Inc. [read post]
12 Sep 2007, 4:59 am
Lupin, LTD., et al. [read post]
7 Feb 2013, 1:25 pm
Lupin, Ltd., et al., C.A. [read post]
28 Jul 2010, 12:06 am
Lupin Pharmaceuticals, Inc. et al. [read post]
28 May 2010, 9:30 am
Lupin Pharmaceuticals Inc., No. 2009-1362 (Fed. [read post]
2 Jan 2008, 9:05 pm
Lupin Limited et al Teva Pharmaceutical Industries Ltd. et al v Hetero Drugs Ltd. [read post]
10 Feb 2010, 4:47 pm
Lupin Pharmaceuticals, Inc. et al. [read post]
28 Dec 2008, 2:24 pm
Lupin Pharmaceuticals, Inc. et al.3:08-cv-06261;... [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
19 Jul 2010, 1:12 pm
Court of Appeals for the Federal Circuit denied Lupin Pharmaceuticals, Inc. [read post]
